Optimisation of a novel hybrid vaccine for liver fluke disease in cattle. Optimisation of a novel hybrid vaccine for liver fluke disease in cattle. This project aims to optimise the formulation of novel fluke vaccine antigens by constructing combination hybrid recombinant antigens and using a protein adjuvant to improve immunogenicity, and test new antigens expressed in young flukes as vaccines and evaluate their ability to synergise with hybrid vaccines. Fasciola (fluke) infections cause seriou ....Optimisation of a novel hybrid vaccine for liver fluke disease in cattle. Optimisation of a novel hybrid vaccine for liver fluke disease in cattle. This project aims to optimise the formulation of novel fluke vaccine antigens by constructing combination hybrid recombinant antigens and using a protein adjuvant to improve immunogenicity, and test new antigens expressed in young flukes as vaccines and evaluate their ability to synergise with hybrid vaccines. Fasciola (fluke) infections cause serious economic losses to livestock production and fluke drug resistance threatens control, so new therapies such as a vaccine are needed. These vaccines should be evaluated in cattle trials. The major outcome plan is validation of hybrid antigens for commercial vaccine development for fluke control in cattle, leading to more sustainable beef and milk production in Australia.Read moreRead less
Targeted drug discovery against blood-feeding parasite nematodes of animals. This project aims to identify more sustainable control strategies of nematode parasites of livestock, which cost more than 400 million yearly to the Australian wool and meat industry. The project expects to identify novel nematicides and generate knowledge of the parasite biology using a combination of high-throughput drug discovery screens with cutting-edge OMICs approaches to target a key molecular pathway of importan ....Targeted drug discovery against blood-feeding parasite nematodes of animals. This project aims to identify more sustainable control strategies of nematode parasites of livestock, which cost more than 400 million yearly to the Australian wool and meat industry. The project expects to identify novel nematicides and generate knowledge of the parasite biology using a combination of high-throughput drug discovery screens with cutting-edge OMICs approaches to target a key molecular pathway of importance to the survival of nematodes, namely their blood-feeding behaviour. Expected outcomes of this project include a likely enhancement of international efforts in controlling these parasites as well as nematicides commercialisation. This should provide significant benefits to agricultural producers in Australia and worldwide.
Read moreRead less
Development of a novel vaccine targeting parasite tegument proteins for liver fluke disease in livestock. Liver fluke parasites cause serious economic losses for livestock producers in South-East Australia, but drug resistance threatens parasite control and economic productivity in rural communities. This project will use novel technologies to identify lead vaccine candidates for improved fluke control to sustain agricultural productivity.